In sarcoma 180 cells, EGCG controls the G2/M phase of the cell cycle by upregulating p53 and Bax while downregulating C‐Myc, Bcl‐2, and spliceosomal uridylate‐rich small nuclear RNA (UsnRNA), U1B, and U4‐U6 (Manna et al. 2006). The gene discussed is TP53; the disease is sarcoma.